INSPIREMD 1/18 DL-0001 (II2) - Cash Flow Conversion Efficiency
Based on the latest financial reports, INSPIREMD 1/18 DL-0001 (II2) has a cash flow conversion efficiency ratio of -0.169x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-9.35 Million ≈ $-10.93 Million USD) by net assets (€55.20 Million ≈ $64.54 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see INSPIREMD 1/18 DL-0001 (II2) total market value for the company's overall valuation and market capitalisation.
INSPIREMD 1/18 DL-0001 - Cash Flow Conversion Efficiency Trend (2021–2025)
This chart illustrates how INSPIREMD 1/18 DL-0001's cash flow conversion efficiency has evolved over time, based on yearly financial data.
INSPIREMD 1/18 DL-0001 Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of INSPIREMD 1/18 DL-0001 ranked by their cash flow conversion efficiency. See debt repayment capacity of INSPIREMD 1/18 DL-0001 to evaluate how effectively operating cash flow covers total debt obligations.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
CItech Co Ltd
KO:004920
|
-0.026x |
|
BOS Better Online Solutions
NASDAQ:BOSC
|
0.176x |
|
Century Casinos Inc
NASDAQ:CNTY
|
-0.241x |
|
North Energy ASA
OL:NORTH
|
-0.014x |
|
Quonia SOCIMI SA
MC:YQUO
|
0.013x |
|
Penguen Gida Sanayi AS
IS:PENGD
|
0.009x |
|
Tera Software Limited
NSE:TERASOFT
|
-0.055x |
|
I Yuan Precision Ind Co Ltd
TWO:2235
|
0.025x |
Annual Cash Flow Conversion Efficiency for INSPIREMD 1/18 DL-0001 (2021–2025)
The table below shows the annual cash flow conversion efficiency of INSPIREMD 1/18 DL-0001 from 2021 to 2025. View INSPIREMD 1/18 DL-0001 stock quote for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | €55.20 Million ≈ $64.54 Million |
€-35.10 Million ≈ $-41.04 Million |
-0.636x | -4.94% |
| 2024-12-31 | €36.09 Million ≈ $42.19 Million |
€-21.87 Million ≈ $-25.57 Million |
-0.606x | -46.17% |
| 2023-12-31 | €39.50 Million ≈ $46.18 Million |
€-16.38 Million ≈ $-19.15 Million |
-0.415x | +53.61% |
| 2022-12-31 | €17.39 Million ≈ $20.33 Million |
€-15.54 Million ≈ $-18.17 Million |
-0.894x | -126.82% |
| 2021-12-31 | €33.53 Million ≈ $39.20 Million |
€-13.21 Million ≈ $-15.44 Million |
-0.394x | -- |
About INSPIREMD 1/18 DL-0001
InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery disease and other vascular conditions in the United States, Germany, Italy, Russia, Poland, and internationally. It offers MicroNet, a biocompatible polymer mesh material for medical implants, as well as for treating plaque prolapse and embolization; CGuard c… Read more